Hybio Pharmaceutical (300199) — Cash Flow Quality Index
Hybio Pharmaceutical (300199) has a Cash Flow Quality Index of 1.54x as of June 2025. Operating cash flow of CN¥116.72 Million exceeds net income of CN¥75.60 Million, indicating high earnings quality where cash backs reported profits. Explore Hybio Pharmaceutical (300199) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hybio Pharmaceutical Cash Flow Quality Index (2008–2021)
Historical Cash Flow Quality Index for Hybio Pharmaceutical across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Hybio Pharmaceutical to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hybio Pharmaceutical (2008–2021)
Year-by-year earnings quality comparison for Hybio Pharmaceutical. For live market cap and the full company financial profile, see market cap of Hybio Pharmaceutical.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 5.52x | CN¥156.83 Million | CN¥28.44 Million | ▲ +750.8% |
| 2017 | 0.65x | CN¥213.74 Million | CN¥329.72 Million | ▼ -36.2% |
| 2016 | 1.02x | CN¥296.41 Million | CN¥291.92 Million | ▲ +123.3% |
| 2015 | 0.45x | CN¥138.84 Million | CN¥305.34 Million | ▼ -49.2% |
| 2014 | 0.89x | CN¥153.43 Million | CN¥171.56 Million | ▼ -24.3% |
| 2013 | 1.18x | CN¥153.48 Million | CN¥129.93 Million | ▲ +21.7% |
| 2012 | 0.97x | CN¥87.19 Million | CN¥89.80 Million | ▲ +7.8% |
| 2011 | 0.90x | CN¥72.48 Million | CN¥80.47 Million | ▼ -13.0% |
| 2010 | 1.03x | CN¥54.69 Million | CN¥52.85 Million | ▲ +40.2% |
| 2009 | 0.74x | CN¥26.11 Million | CN¥35.37 Million | ▼ -68.0% |
| 2008 | 2.30x | CN¥45.75 Million | CN¥19.86 Million | — |